Paper

Translating Innovation to Clinic: End‐to‐End Bioprocess Development and cGMP Manufacturing of N332‐GT5 HIV Vaccine Candidate for First‐In‐Human Trials (HVTN144)

Biotechnology and Bioengineering · 2026 · Sammaiah Pallerla, Shaunak D Uplekar, Ferenc Boldog et al.